Cargando…
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemi...
Autores principales: | Baay, Marc, Lina, Bruno, Fontanet, Arnaud, Marchant, Arnaud, Saville, Melanie, Sabot, Philippe, Duclos, Philippe, Vandeputte, Joris, Neels, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309765/ https://www.ncbi.nlm.nih.gov/pubmed/32600951 http://dx.doi.org/10.1016/j.biologicals.2020.06.005 |
Ejemplares similares
-
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
por: Baay, Marc, et al.
Publicado: (2021) -
Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development
por: Baay, Marc, et al.
Publicado: (2021) -
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
por: Baay, Marc, et al.
Publicado: (2020) -
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
por: Vandeputte, Joris, et al.
Publicado: (2021) -
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?
por: Vandeputte, J., et al.
Publicado: (2021)